149 related articles for article (PubMed ID: 22486944)
1. Effect of magnetite nanoparticles on living rate of MCF-7 human breast cancer cells.
Baba D; Seiko Y; Nakanishi T; Zhang H; Arakaki A; Matsunaga T; Osaka T
Colloids Surf B Biointerfaces; 2012 Jun; 95():254-7. PubMed ID: 22486944
[TBL] [Abstract][Full Text] [Related]
2. Effect of surface charge of magnetite nanoparticles on their internalization into breast cancer and umbilical vein endothelial cells.
Osaka T; Nakanishi T; Shanmugam S; Takahama S; Zhang H
Colloids Surf B Biointerfaces; 2009 Jul; 71(2):325-30. PubMed ID: 19361963
[TBL] [Abstract][Full Text] [Related]
3. Anticancer drug-loaded gliadin nanoparticles induce apoptosis in breast cancer cells.
Gulfam M; Kim JE; Lee JM; Ku B; Chung BH; Chung BG
Langmuir; 2012 May; 28(21):8216-23. PubMed ID: 22568862
[TBL] [Abstract][Full Text] [Related]
4. The anticancer activity of chloroquine-gold nanoparticles against MCF-7 breast cancer cells.
Joshi P; Chakraborti S; Ramirez-Vick JE; Ansari ZA; Shanker V; Chakrabarti P; Singh SP
Colloids Surf B Biointerfaces; 2012 Jun; 95():195-200. PubMed ID: 22445746
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro anti-cancer evaluation of tamoxifen-loaded magnetite/PLLA composite nanoparticles.
Hu FX; Neoh KG; Kang ET
Biomaterials; 2006 Nov; 27(33):5725-33. PubMed ID: 16890989
[TBL] [Abstract][Full Text] [Related]
6. Fe3O4 Nanoparticles Mediated Synthesis of Novel Isatin-dihydropyrimidinone Hybrid Molecules as Antioxidant and Cytotoxic Agents.
Maddela S; Makula A; Jayarambabu N
Anticancer Agents Med Chem; 2017; 17(3):456-463. PubMed ID: 27173964
[TBL] [Abstract][Full Text] [Related]
7. Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy.
Wang AZ; Bagalkot V; Vasilliou CC; Gu F; Alexis F; Zhang L; Shaikh M; Yuet K; Cima MJ; Langer R; Kantoff PW; Bander NH; Jon S; Farokhzad OC
ChemMedChem; 2008 Sep; 3(9):1311-5. PubMed ID: 18613203
[No Abstract] [Full Text] [Related]
8. Synergistic combination of antioxidants, silver nanoparticles and chitosan in a nanoparticle based formulation: Characterization and cytotoxic effect on MCF-7 breast cancer cell lines.
Nayak D; Minz AP; Ashe S; Rauta PR; Kumari M; Chopra P; Nayak B
J Colloid Interface Sci; 2016 May; 470():142-152. PubMed ID: 26939078
[TBL] [Abstract][Full Text] [Related]
9. Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB).
Arulmozhi V; Pandian K; Mirunalini S
Colloids Surf B Biointerfaces; 2013 Oct; 110():313-20. PubMed ID: 23732810
[TBL] [Abstract][Full Text] [Related]
10. Enhanced drug loading on magnetic nanoparticles by layer-by-layer assembly using drug conjugates: blood compatibility evaluation and targeted drug delivery in cancer cells.
Manju S; Sreenivasan K
Langmuir; 2011 Dec; 27(23):14489-96. PubMed ID: 21988497
[TBL] [Abstract][Full Text] [Related]
11. New titanocene derivatives with high antiproliferative activity against breast cancer cells.
Saturnino C; Sirignano E; Botta A; Sinicropi MS; Caruso A; Pisano A; Lappano R; Maggiolini M; Longo P
Bioorg Med Chem Lett; 2014 Jan; 24(1):136-40. PubMed ID: 24332626
[TBL] [Abstract][Full Text] [Related]
12. One-pot solvothermal synthesis of FePt/Fe3O4 core-shell nanoparticles.
Lai CW; Wang YH; Uttam BP; Chen YC; Hsiao JK; Liu CL; Liu HM; Chen CY; Chou PT
Chem Commun (Camb); 2008 Nov; (42):5342-4. PubMed ID: 18985204
[TBL] [Abstract][Full Text] [Related]
13. Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery.
Lee JE; Lee N; Kim H; Kim J; Choi SH; Kim JH; Kim T; Song IC; Park SP; Moon WK; Hyeon T
J Am Chem Soc; 2010 Jan; 132(2):552-7. PubMed ID: 20017538
[TBL] [Abstract][Full Text] [Related]
14. "Clickable", trifunctional magnetite nanoparticles and their chemoselective biofunctionalization.
Das M; Bandyopadhyay D; Mishra D; Datir S; Dhak P; Jain S; Maiti TK; Basak A; Pramanik P
Bioconjug Chem; 2011 Jun; 22(6):1181-93. PubMed ID: 21545182
[TBL] [Abstract][Full Text] [Related]
15. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
Yallapu MM; Gupta BK; Jaggi M; Chauhan SC
J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257
[TBL] [Abstract][Full Text] [Related]
16. Heparin-paclitaxel conjugates as drug delivery system: synthesis, self-assembly property, drug release, and antitumor activity.
Wang Y; Xin D; Liu K; Zhu M; Xiang J
Bioconjug Chem; 2009 Dec; 20(12):2214-21. PubMed ID: 19950889
[TBL] [Abstract][Full Text] [Related]
17. Sonochemical synthesis of versatile hydrophilic magnetite nanoparticles.
Marchegiani G; Imperatori P; Mari A; Pilloni L; Chiolerio A; Allia P; Tiberto P; Suber L
Ultrason Sonochem; 2012 Jul; 19(4):877-82. PubMed ID: 22236507
[TBL] [Abstract][Full Text] [Related]
18. Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer.
Chen J; Li S; Shen Q; He H; Zhang Y
Drug Dev Ind Pharm; 2011 Nov; 37(11):1339-46. PubMed ID: 21524153
[TBL] [Abstract][Full Text] [Related]
19. Novel purine thioglycoside analogs: synthesis, nanoformulation and biological evaluation in in vitro human liver and breast cancer models.
Abu-Zaied MA; Loutfy SA; Hassan AE; Elgemeie GH
Drug Des Devel Ther; 2019; 13():2437-2457. PubMed ID: 31440030
[No Abstract] [Full Text] [Related]
20. Synthesis and characterisation of arsenic nanoparticles and its interaction with DNA and cytotoxic potential on breast cancer cells.
Subastri A; Arun V; Sharma P; Preedia Babu E; Suyavaran A; Nithyananthan S; Alshammari GM; Aristatile B; Dharuman V; Thirunavukkarasu C
Chem Biol Interact; 2018 Nov; 295():73-83. PubMed ID: 29277637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
